doi: 10.1016/j.scr.2021.102651.
Epub 2021 Dec 31.
Generation of induced pluripotent stem cell line, ICGi034-A, by reprogramming peripheral blood mononuclear cells from a patient with Parkinson's disease associated with GBA mutation
Affiliations
- PMID: 35007918
- DOI: 10.1016/j.scr.2021.102651
Item in Clipboard
Generation of induced pluripotent stem cell line, ICGi034-A, by reprogramming peripheral blood mononuclear cells from a patient with Parkinson's disease associated with GBA mutation
Stem Cell Res.
2022 Mar.
Free article
Abstract
Mutation in the glucocerebrosidase encoding gene (GBA) is one of the most frequent genetic cause of Parkinson's disease. ICGi034-A induced pluripotent stem cell (iPSC) line obtained by reprogramming peripheral blood mononuclear cells (PBMCs) of a patient with heterozygous c.1226A > G (p.N370S) mutation in the GBA gene can be used for studying the fundamental mechanisms of the pathogenesis of GBA-associated Parkinson's disease, and for potential drug screening. The iPSCs express pluripotency markers (NANOG, SSEA4, TRA-1-60, OCT4, SOX2), have a normal karyotype, and are capable of producing derivatives of three germ layers.
Copyright © 2022 The Authors. Published by Elsevier B.V. All rights reserved.
Similar articles
-
IPSC-Derived Astrocytes Contribute to In Vitro Modeling of Parkinson's Disease Caused by the GBA1 N370S Mutation.Int J Mol Sci. 2023 Dec 26;25(1):327. doi: 10.3390/ijms25010327. Int J Mol Sci. 2023. PMID: 38203497 Free PMC article.
-
Human induced pluripotent stem cells line (PNUSCRi002-A) from a patient with Parkinson's disease carrying a R159W mutation in the GBA gene.Stem Cell Res. 2022 Dec;65:102948. doi: 10.1016/j.scr.2022.102948. Epub 2022 Oct 17. Stem Cell Res. 2022. PMID: 36274270
-
Generation of Parkinson's disease patient-derived human induced pluripotent stem cells line (PNUSCRi001-A) carrying a N227S mutation in GBA gene.Stem Cell Res. 2022 Dec;65:102959. doi: 10.1016/j.scr.2022.102959. Epub 2022 Oct 31. Stem Cell Res. 2022. PMID: 36332465
-
Insights into GBA Parkinson's disease pathology and therapy with induced pluripotent stem cell model systems.Neurobiol Dis. 2019 Jul;127:1-12. doi: 10.1016/j.nbd.2019.01.023. Epub 2019 Jan 31. Neurobiol Dis. 2019. PMID: 30711484 Review.
-
Advances in GBA-associated Parkinson's disease--Pathology, presentation and therapies.Neurochem Int. 2016 Feb;93:6-25. doi: 10.1016/j.neuint.2015.12.004. Epub 2015 Dec 30. Neurochem Int. 2016. PMID: 26743617 Review.
Cited by
-
Modeling Alzheimer's Disease: A Review of Gene-Modified and Induced Animal Models, Complex Cell Culture Models, and Computational Modeling.Brain Sci. 2025 May 5;15(5):486. doi: 10.3390/brainsci15050486. Brain Sci. 2025. PMID: 40426657 Free PMC article. Review.
-
Detection of ER Stress in iPSC-Derived Neurons Carrying the p.N370S Mutation in the GBA1 Gene.Biomedicines. 2024 Mar 27;12(4):744. doi: 10.3390/biomedicines12040744. Biomedicines. 2024. PMID: 38672099 Free PMC article.
-
Biochemical Characteristics of iPSC-Derived Dopaminergic Neurons from N370S GBA Variant Carriers with and without Parkinson's Disease.Int J Mol Sci. 2023 Feb 23;24(5):4437. doi: 10.3390/ijms24054437. Int J Mol Sci. 2023. PMID: 36901867 Free PMC article.
-
Potential Binding Sites of Pharmacological Chaperone NCGC00241607 on Mutant β-Glucocerebrosidase and Its Efficacy on Patient-Derived Cell Cultures in Gaucher and Parkinson's Disease.Int J Mol Sci. 2023 May 22;24(10):9105. doi: 10.3390/ijms24109105. Int J Mol Sci. 2023. PMID: 37240451 Free PMC article.
-
Ultrastructural Abnormalities in Induced Pluripotent Stem Cell-Derived Neural Stem Cells and Neurons of Two Cohen Syndrome Patients.Cells. 2023 Nov 25;12(23):2702. doi: 10.3390/cells12232702. Cells. 2023. PMID: 38067130 Free PMC article.
LinkOut - more resources
Full Text Sources
Research Materials
